[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Amino Acid Metabolism Disorders Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

August 2022 | 86 pages | ID: GC35F369F943EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Amino Acid Metabolism Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Amino Acid Metabolism Disorders Treatment market size is estimated to be worth US$ 562.8 million in 2021 and is forecast to a readjusted size of USD 795.8 million by 2028 with a CAGR of 5.1% during review period. Phenylketonuria accounting for % of the Amino Acid Metabolism Disorders Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Arginine segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Amino Acid Metabolism Disorders Treatment include GlaxoSmithKline, Pfizer, AMINO, Merck, and Recordati, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Amino Acid Metabolism Disorders Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Arginine
  • Folic Acid
  • Vitamin B6 & B12
  • Thiamine
  • Vitamin D
  • Betaine
  • Carglumic Acid
  • Sapropterin Dihydrochloride
  • Others
Market segment by Application, can be divided into
  • Phenylketonuria
  • Maple Syrup Urine Disease
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria
Market segment by players, this report covers
  • GlaxoSmithKline
  • Pfizer
  • AMINO
  • Merck
  • Recordati
  • Koninklijke
  • Sanofi
  • Shine Star (Hubei) Biological Engineering
  • Kyowa Hakko Kirin
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Amino Acid Metabolism Disorders Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Amino Acid Metabolism Disorders Treatment, with revenue, gross margin and global market share of Amino Acid Metabolism Disorders Treatment from 2019 to 2022.

Chapter 3, the Amino Acid Metabolism Disorders Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Amino Acid Metabolism Disorders Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Amino Acid Metabolism Disorders Treatment research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Amino Acid Metabolism Disorders Treatment
1.2 Classification of Amino Acid Metabolism Disorders Treatment by Type
  1.2.1 Overview: Global Amino Acid Metabolism Disorders Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Type in 2021
  1.2.3 Arginine
  1.2.4 Folic Acid
  1.2.5 Vitamin B6 & B12
  1.2.6 Thiamine
  1.2.7 Vitamin D
  1.2.8 Betaine
  1.2.9 Carglumic Acid
  1.2.10 Sapropterin Dihydrochloride
  1.2.11 Others
1.3 Global Amino Acid Metabolism Disorders Treatment Market by Application
  1.3.1 Overview: Global Amino Acid Metabolism Disorders Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Phenylketonuria
  1.3.3 Maple Syrup Urine Disease
  1.3.4 Argininosuccinic Acidemia
  1.3.5 Citrullinemia
  1.3.6 Homocystinuria
1.4 Global Amino Acid Metabolism Disorders Treatment Market Size & Forecast
1.5 Global Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Region
  1.5.1 Global Amino Acid Metabolism Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Amino Acid Metabolism Disorders Treatment Market Size by Region, (2017-2022)
  1.5.3 North America Amino Acid Metabolism Disorders Treatment Market Size and Prospect (2017-2028)
  1.5.4 Europe Amino Acid Metabolism Disorders Treatment Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Amino Acid Metabolism Disorders Treatment Market Size and Prospect (2017-2028)
  1.5.6 South America Amino Acid Metabolism Disorders Treatment Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Amino Acid Metabolism Disorders Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Amino Acid Metabolism Disorders Treatment Market Drivers
  1.6.2 Amino Acid Metabolism Disorders Treatment Market Restraints
  1.6.3 Amino Acid Metabolism Disorders Treatment Trends Analysis

2 COMPANY PROFILES

2.1 GlaxoSmithKline
  2.1.1 GlaxoSmithKline Details
  2.1.2 GlaxoSmithKline Major Business
  2.1.3 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.1.4 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Pfizer
  2.2.1 Pfizer Details
  2.2.2 Pfizer Major Business
  2.2.3 Pfizer Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.2.4 Pfizer Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Pfizer Recent Developments and Future Plans
2.3 AMINO
  2.3.1 AMINO Details
  2.3.2 AMINO Major Business
  2.3.3 AMINO Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.3.4 AMINO Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 AMINO Recent Developments and Future Plans
2.4 Merck
  2.4.1 Merck Details
  2.4.2 Merck Major Business
  2.4.3 Merck Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.4.4 Merck Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Merck Recent Developments and Future Plans
2.5 Recordati
  2.5.1 Recordati Details
  2.5.2 Recordati Major Business
  2.5.3 Recordati Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.5.4 Recordati Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Recordati Recent Developments and Future Plans
2.6 Koninklijke
  2.6.1 Koninklijke Details
  2.6.2 Koninklijke Major Business
  2.6.3 Koninklijke Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.6.4 Koninklijke Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Koninklijke Recent Developments and Future Plans
2.7 Sanofi
  2.7.1 Sanofi Details
  2.7.2 Sanofi Major Business
  2.7.3 Sanofi Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.7.4 Sanofi Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Sanofi Recent Developments and Future Plans
2.8 Shine Star (Hubei) Biological Engineering
  2.8.1 Shine Star (Hubei) Biological Engineering Details
  2.8.2 Shine Star (Hubei) Biological Engineering Major Business
  2.8.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.8.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Shine Star (Hubei) Biological Engineering Recent Developments and Future Plans
2.9 Kyowa Hakko Kirin
  2.9.1 Kyowa Hakko Kirin Details
  2.9.2 Kyowa Hakko Kirin Major Business
  2.9.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Product and Solutions
  2.9.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Kyowa Hakko Kirin Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Amino Acid Metabolism Disorders Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Amino Acid Metabolism Disorders Treatment Players Market Share in 2021
  3.2.2 Top 10 Amino Acid Metabolism Disorders Treatment Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Amino Acid Metabolism Disorders Treatment Players Head Office, Products and Services Provided
3.4 Amino Acid Metabolism Disorders Treatment Mergers & Acquisitions
3.5 Amino Acid Metabolism Disorders Treatment New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Amino Acid Metabolism Disorders Treatment Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Amino Acid Metabolism Disorders Treatment Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2028)
6.2 North America Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2028)
6.3 North America Amino Acid Metabolism Disorders Treatment Market Size by Country
  6.3.1 North America Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2028)
  6.3.2 United States Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  6.3.3 Canada Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  6.3.4 Mexico Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2028)
7.2 Europe Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2028)
7.3 Europe Amino Acid Metabolism Disorders Treatment Market Size by Country
  7.3.1 Europe Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2028)
  7.3.2 Germany Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  7.3.3 France Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  7.3.5 Russia Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  7.3.6 Italy Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Amino Acid Metabolism Disorders Treatment Market Size by Region
  8.3.1 Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Region (2017-2028)
  8.3.2 China Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  8.3.3 Japan Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  8.3.4 South Korea Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  8.3.5 India Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  8.3.7 Australia Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2028)
9.2 South America Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2028)
9.3 South America Amino Acid Metabolism Disorders Treatment Market Size by Country
  9.3.1 South America Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2028)
  9.3.2 Brazil Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  9.3.3 Argentina Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Size by Country
  10.3.1 Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2028)
  10.3.2 Turkey Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)
  10.3.4 UAE Amino Acid Metabolism Disorders Treatment Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Amino Acid Metabolism Disorders Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Amino Acid Metabolism Disorders Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Amino Acid Metabolism Disorders Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Amino Acid Metabolism Disorders Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Region (2023-2028)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 9. GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 13. Pfizer Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. AMINO Corporate Information, Head Office, and Major Competitors
Table 15. AMINO Major Business
Table 16. AMINO Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 17. AMINO Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 21. Merck Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Recordati Corporate Information, Head Office, and Major Competitors
Table 23. Recordati Major Business
Table 24. Recordati Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 25. Recordati Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Koninklijke Corporate Information, Head Office, and Major Competitors
Table 27. Koninklijke Major Business
Table 28. Koninklijke Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 29. Koninklijke Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 33. Sanofi Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Shine Star (Hubei) Biological Engineering Corporate Information, Head Office, and Major Competitors
Table 35. Shine Star (Hubei) Biological Engineering Major Business
Table 36. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 37. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Kyowa Hakko Kirin Corporate Information, Head Office, and Major Competitors
Table 39. Kyowa Hakko Kirin Major Business
Table 40. Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Product and Solutions
Table 41. Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Amino Acid Metabolism Disorders Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Amino Acid Metabolism Disorders Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Amino Acid Metabolism Disorders Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Amino Acid Metabolism Disorders Treatment Players Head Office, Products and Services Provided
Table 46. Amino Acid Metabolism Disorders Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Amino Acid Metabolism Disorders Treatment New Entrants and Expansion Plans
Table 48. Global Amino Acid Metabolism Disorders Treatment Revenue (USD Million) by Type (2017-2022)
Table 49. Global Amino Acid Metabolism Disorders Treatment Revenue Share by Type (2017-2022)
Table 50. Global Amino Acid Metabolism Disorders Treatment Revenue Forecast by Type (2023-2028)
Table 51. Global Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022)
Table 52. Global Amino Acid Metabolism Disorders Treatment Revenue Forecast by Application (2023-2028)
Table 53. North America Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Amino Acid Metabolism Disorders Treatment Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Amino Acid Metabolism Disorders Treatment Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Amino Acid Metabolism Disorders Treatment Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Amino Acid Metabolism Disorders Treatment Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Amino Acid Metabolism Disorders Treatment Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Amino Acid Metabolism Disorders Treatment Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Amino Acid Metabolism Disorders Treatment Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Amino Acid Metabolism Disorders Treatment Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Amino Acid Metabolism Disorders Treatment Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Amino Acid Metabolism Disorders Treatment Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Amino Acid Metabolism Disorders Treatment Picture
Figure 2. Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Type in 2021
Figure 3. Arginine
Figure 4. Folic Acid
Figure 5. Vitamin B6 & B12
Figure 6. Thiamine
Figure 7. Vitamin D
Figure 8. Betaine
Figure 9. Carglumic Acid
Figure 10. Sapropterin Dihydrochloride
Figure 11. Others
Figure 12. Amino Acid Metabolism Disorders Treatment Revenue Market Share by Application in 2021
Figure 13. Phenylketonuria Picture
Figure 14. Maple Syrup Urine Disease Picture
Figure 15. Argininosuccinic Acidemia Picture
Figure 16. Citrullinemia Picture
Figure 17. Homocystinuria Picture
Figure 18. Global Amino Acid Metabolism Disorders Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 19. Global Amino Acid Metabolism Disorders Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Region (2017-2028)
Figure 21. Global Amino Acid Metabolism Disorders Treatment Revenue Market Share by Region in 2021
Figure 22. North America Amino Acid Metabolism Disorders Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Europe Amino Acid Metabolism Disorders Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. South America Amino Acid Metabolism Disorders Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Middle East and Africa Amino Acid Metabolism Disorders Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 27. Amino Acid Metabolism Disorders Treatment Market Drivers
Figure 28. Amino Acid Metabolism Disorders Treatment Market Restraints
Figure 29. Amino Acid Metabolism Disorders Treatment Market Trends
Figure 30. GlaxoSmithKline Recent Developments and Future Plans
Figure 31. Pfizer Recent Developments and Future Plans
Figure 32. AMINO Recent Developments and Future Plans
Figure 33. Merck Recent Developments and Future Plans
Figure 34. Recordati Recent Developments and Future Plans
Figure 35. Koninklijke Recent Developments and Future Plans
Figure 36. Sanofi Recent Developments and Future Plans
Figure 37. Shine Star (Hubei) Biological Engineering Recent Developments and Future Plans
Figure 38. Kyowa Hakko Kirin Recent Developments and Future Plans
Figure 39. Global Amino Acid Metabolism Disorders Treatment Revenue Share by Players in 2021
Figure 40. Amino Acid Metabolism Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Amino Acid Metabolism Disorders Treatment Revenue Market Share in 2021
Figure 42. Global Top 10 Players Amino Acid Metabolism Disorders Treatment Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Amino Acid Metabolism Disorders Treatment Revenue Share by Type in 2021
Figure 45. Global Amino Acid Metabolism Disorders Treatment Market Share Forecast by Type (2023-2028)
Figure 46. Global Amino Acid Metabolism Disorders Treatment Revenue Share by Application in 2021
Figure 47. Global Amino Acid Metabolism Disorders Treatment Market Share Forecast by Application (2023-2028)
Figure 48. North America Amino Acid Metabolism Disorders Treatment Sales Market Share by Type (2017-2028)
Figure 49. North America Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2017-2028)
Figure 50. North America Amino Acid Metabolism Disorders Treatment Revenue Market Share by Country (2017-2028)
Figure 51. United States Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Amino Acid Metabolism Disorders Treatment Sales Market Share by Type (2017-2028)
Figure 55. Europe Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2017-2028)
Figure 56. Europe Amino Acid Metabolism Disorders Treatment Revenue Market Share by Country (2017-2028)
Figure 57. Germany Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Amino Acid Metabolism Disorders Treatment Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue Market Share by Region (2017-2028)
Figure 65. China Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Amino Acid Metabolism Disorders Treatment Sales Market Share by Type (2017-2028)
Figure 72. South America Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2017-2028)
Figure 73. South America Amino Acid Metabolism Disorders Treatment Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Amino Acid Metabolism Disorders Treatment Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Amino Acid Metabolism Disorders Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source


More Publications